Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | GALR2 | O43603 | 1/20 | 0.48 |
| ▸ | MITF | O75030 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | XBP1 | P17861 | 1/20 | 0.48 |
| ▸ | CCR6 | P51684 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 3/20 | 0.46 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27796244 | 0.92 | SLC9A1 (0.56) | MAPTNPSR1SLC9A1HTTKMT2A | |
| SCHEMBL863876 | 0.89 | SLC9A1 (0.53) | MAPTNPSR1SLC9A1HTTKMT2A | |
| SCHEMBL405563 | 0.89 | MAPT (0.51) | MAPTNPSR1SLC9A1HTTKMT2A | |
| SCHEMBL6354726 | 0.88 | SLC9A1 (0.59) | MAPTNPSR1SLC9A1HTTKMT2A | |
| SCHEMBL11252461 | 0.87 | MAPT (0.50) | MAPTNPSR1SLC9A1HTTKMT2A | |
| SCHEMBL21989034 | 0.87 | SLC9A1 (0.52) | MAPTNPSR1SLC9A1HTTKMT2A | |
| SCHEMBL6167927 | 0.87 | MAPT (0.50) | MAPTNPSR1SLC9A1HTTKMT2A | |
| SCHEMBL8611539 | 0.86 | SLC9A1 (0.64) | MAPTNPSR1SLC9A1HTTKMT2A | |
| SCHEMBL3915677 | 0.86 | SLC9A1 (0.51) | MAPTNPSR1SLC9A1HTTKMT2A | |
| SCHEMBL3915656 | 0.85 | SLC9A1 (0.56) | MAPTNPSR1SLC9A1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018091978-A1 | A PROCESS FOR THE PREPARATION OF 2-NITRO-4,5- DICHLOROACETANILIDE | AMOGH CHEMICALS PVT. LTD (IN) | 2018-05-24 | — | — | WO | claimed |
| US-20130303781-A1 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2013-11-14 | — | — | US | claimed |
| EP-2642995-A2 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | Sequent Scientific Ltd. (IN) | 2013-10-02 | — | — | EP | claimed |
| WO-2012070068-A2 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2012-05-31 | — | — | WO | claimed |
| WO-2018091978-A1 | A PROCESS FOR THE PREPARATION OF 2-NITRO-4,5- DICHLOROACETANILIDE | AMOGH CHEMICALS PVT. LTD (IN) | 2018-05-24 | — | — | WO | disclosed |
| WO-2018091978-A1 | A PROCESS FOR THE PREPARATION OF 2-NITRO-4,5- DICHLOROACETANILIDE | AMOGH CHEMICALS PVT. LTD (IN) | 2018-05-24 | — | — | WO | disclosed |
| WO-2018091978-A1 | A PROCESS FOR THE PREPARATION OF 2-NITRO-4,5- DICHLOROACETANILIDE | AMOGH CHEMICALS PVT. LTD (IN) | 2018-05-24 | — | — | WO | disclosed |
| US-20130303781-A1 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2013-11-14 | — | — | US | disclosed |
| US-20130303781-A1 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2013-11-14 | — | — | US | disclosed |
| US-20130303781-A1 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2013-11-14 | — | — | US | disclosed |
| US-20130303781-A1 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2013-11-14 | — | — | US | disclosed |
| EP-2642995-A2 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | Sequent Scientific Ltd. (IN) | 2013-10-02 | — | — | EP | disclosed |
| EP-2642995-A2 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | Sequent Scientific Ltd. (IN) | 2013-10-02 | — | — | EP | disclosed |
| WO-2012070068-A3 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2012-07-19 | — | — | WO | disclosed |
| WO-2012070068-A2 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2012-05-31 | — | — | WO | disclosed |
| WO-2012070068-A2 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | SEQUENT SCIENTIFIC LIMITED (IN) | 2012-05-31 | — | — | WO | disclosed |
| US-7763616-B2 | Piperazine-piperidines with CXCR3 antagonist activity | SCHERING CORPORATION (US) | 2010-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303781-A1 | PROCESS FOR PREPARATION OF TRICLABENDAZOLE | NIT2, CA3, TET3 | MAPT 4414/4885NPSR1 2807/4885SLC9A1 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.